Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002914998 | SCV003268720 | uncertain significance | Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase | 2022-05-22 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 316 of the AHCY protein (p.Val316Met). This variant is present in population databases (rs140039996, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with AHCY-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV003348946 | SCV004061034 | uncertain significance | Inborn genetic diseases | 2023-08-16 | criteria provided, single submitter | clinical testing | The c.946G>A (p.V316M) alteration is located in exon 8 (coding exon 8) of the AHCY gene. This alteration results from a G to A substitution at nucleotide position 946, causing the valine (V) at amino acid position 316 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |